Low distribution of integrous among multidrug resistant E. coli strains isolated from children with community-acquired urinary tract infections in Shiraz, Iran

• Autorzy: Farshad S , Japoni A. , Hosseini M.
• Języki publikacji: EN

Abstrakty

EN

Although integrons by themselves are not mobile, due to their presence in plasmids and transposons, they can be transferred horizontally. For these reasons integrons are a major mechanism for the spread and maintenance of multidrug resistance (MDR). This study describes the distribution of integron gene cassette classes in a collection of uropathogenic Escherichia coli (UPEC) isolated from children with community acquired urinary tract infection in Jahrom, Iran. E. coli strains isolated from urine samples were tested for susceptibility to 14 different antibiotics using the disk diffusion method and for integron classes by RFLP-PCR. Totally 96 strains of E. coli were isolated from urine samples. High prevalence of resistance to ampicillin (80.2%), co-trimoxazole ((76%) and tetracycline (70.8%) was seen among the UPEC isolates. All isolates were 100% sensitive to imipenem. Sixteen strains (16.6%) had the evidence of integron sequences with the prevalence of 6.25% (n = 6) and 10.41% (n = 10) for intI1 and intI2, respectively. No intI3 was detected in the isolates. The presence of integrons was significantly associated with resistance to certain antibiotics including gentamicin and ampicillin. Considering the MDR patterns and the low prevalence of integrons among the E. coli strains under the study, we suggest that the antibiotic resistance cassettes in these strains presumably are mostly carried on the other transposable elements rather than integrons.

Słowa kluczowe

EN

integron; infectious disease; antibiotic sensitivity; urinary tract; Escherichia coli; human disease; Shiraz; multidrug resistance; child; Iran

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2008
• Tom: 57
• Numer: 3
• Opis fizyczny: p.193-198,ref.

Twórcy

autor

Farshad S

• Shiraz University of Medical Sciences, Nemazee Hospital, Shiraz 71937-11351, Iran

autor

Japoni A.

autor

Hosseini M.

Bibliografia

• Adwan K., N. Abu-Hasan, G. Adwan, N. Jarrar, B. Abu-Shanab and M. Al-Masri. 2004. Molecular epidemiology of antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections in Northern Palestine. Pol. J. Microbiol. 53: 23-26.
• Chang L.L., T.M. Chang and C.Y. Chang. 2007. Variable gene cassette patterns of class 1 integron-associated drug-resistant Escherichia coli in Taiwan. Kaohsiun. J. Med. Sci. 23: 273-280.
• Clinical and Laboratory Standard Institute. 2006. Performance standards for antimicrobial susceptibility testing. M100-S16. Wayne, PA: CLSI.
• Fiuit AC. and F.J. Schmitz. 1999. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18: 761-770.
• Gulsun S., N. Oguzoglu, A. Inan and N. Ceran. 2005. The virulence factors and antibiotic sensitivities of Escherichia coli isolated from recurrent urinary tract infections. Saudi. Med. J. 26: 1755-1758.
• Japoni A., M. Gudarzi, SH. Farshad, E. Basiri, M. Ziyaeyan, A. Alborzi and N. Rafaatpour. 2008. Assay for integrons and pattern of antibiotic resistance in clinical Escherichia coli strains by PCR-RFLP in southern Iran. Jpn. J. Infect. Dis. 61: 85-88.
• Johnson J. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4: 80-128.
• Kahlmeter G. 2003. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int. J. Antimicrob Agents 2: 49-52.
• Lee J.C., J.Y. Oh, J.W. Cho, J.C. Park, J.M. Kim, S.Y. Seol and D.T. Cho. 2001. The prevalence of trimethoprim-resistance-conferring dihydrofolate reductase genes in urinary isolates of Escherichia coli in Korea. J. Antimicrob. Chemother. 47: 599-604.
• Martinez-Freijo P., A.C. Fluit, F.J. Schmitz, V.S. Grek, J. Verhoef and M.E. Jones. 1998. Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J. Antimicrob. Chemother. 42: 689-696.
• Mathai E., M. Grape and G. Kronvall. 2004. Integrons and multidrug resistance among Escherichia coli causing community-acquired urinary tract infection in southern India. APMIS 112: 159-164.
• O'Brien T.F. 2002. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin. Infect. Dis. 34: 78-84.
• Olsson-Liljequist B., P. Larsson, M. Walder and H. Miörner. 1997. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand. J. Infect. Dis. 105: 13-23.
• Rao AN., M. Barlow, L.A. Clark, J.R. Boring, F.C. Tenover and J.E. McGowan. 2006. Class 1 integrons in resistant Escherichia coli and Klebsiella spp., US hospitals. Emerg. Infect. Dis. 12: 1011-1014.
• Rijavec M., M. Starcic Erjavec, J. Ambrozic Avgustin, R. Reissbrodt, A. Fruth, V. Krizan-Hergouth and D. Zgur-Bertok. 2006. High prevalence of multidrug resistance and random distribution of mobile genetic elements among uropathogenic Escherichia coli (UPEC) of the four major phylogenetic groups. Curr. Microbiol. 53: 158-162.
• Sallen B., A. Rajoharison, S. Desvarenne and C. Mabilat. 1995. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of Enterobacteriaceae. Microb. Drug Resist. 1: 195-202.
• Sahm D.F., C. Thornsberry, D.C. Mayfield, M.E. Jones and J.A. Karlowsky. 2000. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000. Antimicrob. Agents Chemother. 45: 1402-1406.
• Solberg O.D., R.M. Ajiboye and L.W. Riley. 2006. Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli. J. Clin. Microbiol. 44: 1347-1351.
• Svanborg C. and G. Godaly. 1997. Bacterial virulence in urinary tract infection. Infect. Dis. Clin. North. Am. 11: 513-521.
• Tariq N., T. Jaffery, R. Ayub, A.Y. Alam, M.H. Javid and S. Shafique. 2006. Frequency and antimicrobial susceptibility of aerobic bacterial vaginal isolates. J. Coll. Physicians. Surg. Pak. 16: 196-199.
• Vila J., K. Simon, J. Ruiz, J.P. Horcajada, M. Vclasco, M. Barranco, A. Moreno and J. Mensa. 2002. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J. Infect. Dis. 186: 1039-1042.
• White P.A., C.J. McIver and W.D. Rawlinson. 2001. Integrons and gene cassettes in the Enterobacteriaceae. Antimicrob. Agents Chemother. 45: 2658-2661.
• White P.A., C.J. McIver, Y. Deng and W.D. Rawlinson. 2000. Characterisation of two new gene cassettes, aadAS and dfrA17. FEMS Microbiol. Lett. 182: 265-269.
• World Health Organization. 2001. WHO Global Strategy for Containment of Antimicrobial Resistance. 1-105. Geneva, Switzerland.
• Yu H.S., J.C. Lee, H.Y. Kang, D.W. Ro, J.Y. Chung, Y.S. Jeong, S.H. Tae, CH. Choi, E.Y. Lee, S.Y. Seol and others. 2003. Changes in gene cassettes of class 1 integrons among Escherichia coli isolates from urine specimens collected in Korea during the last two decades. J. Clin. Microbiol. 41: 5429-5433.